# Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/Emtricitabine

> **NCT03836729** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 16 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tenofovir alafenamide/emtricitabine
- **DRUG:** GSK3640254

## Key facts

- **NCT ID:** NCT03836729
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-11
- **Primary completion:** 2019-03-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03836729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03836729, "Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/Emtricitabine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03836729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*